Finding new uses for existing medicines to treat osteoarthritis
Repurposing FDA-approved drugs for the treatment of osteoarthritis using high-throughput screening in microphysiological models
This project looks for new ways to treat osteoarthritis by testing existing medications on advanced lab models that mimic human joints.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11170505 on NIH RePORTER |
What this research studies
Osteoarthritis causes pain and disability for millions, but current treatments only manage symptoms without stopping the disease from getting worse. This project aims to find new treatments by exploring existing FDA-approved drugs, which are already known to be safe for people. Researchers will use special lab models, created from human cells, that can quickly test many drugs to see if they can target specific types of osteoarthritis. This approach helps overcome challenges with traditional animal models and the difficulty of finding new drug targets.
Who could benefit from this research
Good fit: Patients living with osteoarthritis, particularly those with cartilage-driven, bone-driven, or inflammation-driven forms of the condition, could potentially benefit from future treatments developed through this research.
Not a fit: Patients seeking immediate treatment options would not directly benefit from this foundational drug discovery effort, as it is focused on early-stage drug identification.
Why it matters
Potential benefit: If successful, this work could lead to new, effective medications that slow or even reverse the progression of osteoarthritis, offering more than just pain relief.
How similar studies have performed: Repurposing existing drugs has shown promise in other disease areas, making this a practical and efficient strategy for discovering new osteoarthritis treatments.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Lin, Hang — University of Pittsburgh at Pittsburgh
- Study coordinator: Lin, Hang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.